Impaired secretion of active GLP‐1 in patients with hypertriglyceridaemia: A novel lipotoxicity paradigm?

E-ISSN： 1099-0895|34|2|dmrr.2964-dmrr.2964

ISSN： 1520-7552

Source： DIABETES/METABOLISM: RESEARCH AND REVIEWS (ELECT), Vol.34, Iss.2, 2018-02, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endogenous GLP-1 as a key self-defense molecule against lipotoxicity in pancreatic islets

International Journal of Molecular Medicine, Vol. 36, Iss. 1, 2015-01 ,pp. : 173-185

Spandidos Publications

Access to resources Recommend Favorite

Impaired GLP‐1 signaling contributes to reduced sensitivity to duodenal nutrients in obesity‐prone rats during high‐fat feeding

OBESITY, Vol. 23, Iss. 11, 2015-11 ,pp. : 2260-2268

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patients as Active Partners in Research - a Fashionable Phrase or a Fundamental Paradigm Shift?

Forschende Komplementärmedizin / Research in Complementary Medicine, Vol. 22, Iss. 4, 2015-0 ,pp. : 224-225

Karger

Access to resources Recommend Favorite

Lixisenatide, a novel GLP‐1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 16, Iss. 7, 2014-07 ,pp. : 588-601

John Wiley & Sons Inc

Access to resources Recommend Favorite

The CDKAL1 gene is associated with impaired insulin secretion and glucose‐related traits: the Cardiometabolic Risk in Chinese (CRC) study

CLINICAL ENDOCRINOLOGY, Vol. 83, Iss. 5, 2015-11 ,pp. : 651-655

John Wiley & Sons Inc

Access to resources Recommend Favorite